Searchable abstracts of presentations at key conferences in endocrinology

ea0020p674 | Steroid Receptors | ECE2009

Calculated free testosterone as ‘gold standard’ for diagnosis of hypogonadism among HIV-infected men

Moreno-Perez Oscar , Escoin Corina , Serna-Candel Carmen , Arias Nieves , Gonzalez Victor , Alfayate Rocio , Reus Sergio , Mauri Montserrat , Portilla Joaquin , Pico Antonio

Background: HIV-associated hypogonadism is a prevalent endocrine disorder, total testosterone (TT) test is not useful for its diagnosis, Endocrine Society clinical practice guidelines have recently proposed calculated free testosterone (FT) as screening test of hypogonadism in HIV infected men, but no clinical study has been published using this approach in HIV population to date. Our aim was to study prevalence and risk factors for hypogonadism in HIV-infected men using FT.</...

ea0016p87 | Bone and calcium | ECE2008

Clinical experience with Cinacalcet for treatment of persistent primary hyperparathyroidism

Martinez-Fuster Sandra , Gonzalez Victor , Lopez Alicia , Moreno-Perez Oscar , Arias Nieves , Revert Paula , Sanchez Ruth , Boix Evangelina , Pico Antonio Miguel

Introduction: In primary hyperparathyroidism (PHPT) medical treatment is indicated if the patient donot carry out the surgical criterion, donot accept surgery or there is another serious comorbidity that makes impossible the intervention. Cinacalcet is a calcimimetic that increase the sensitivity of the calcium-sensing receptor (CaSR) to ionized serum calcium, decreasing secretion of PTH and serum calcium concentration. This drug is prescribed for secondary hyperparathyroidism...